GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MediClin AG (XTER:MED) » Definitions » 3-Year EBITDA Growth Rate

MediClin AG (XTER:MED) 3-Year EBITDA Growth Rate : 9.30% (As of Dec. 2023)


View and export this data going back to 2000. Start your Free Trial

What is MediClin AG 3-Year EBITDA Growth Rate?

MediClin AG's EBITDA per Share for the three months ended in Dec. 2023 was €0.67.

During the past 12 months, MediClin AG's average EBITDA Per Share Growth Rate was 10.30% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 9.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 15.30% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 16.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of MediClin AG was 141.20% per year. The lowest was -54.50% per year. And the median was -2.20% per year.


Competitive Comparison of MediClin AG's 3-Year EBITDA Growth Rate

For the Medical Care Facilities subindustry, MediClin AG's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


MediClin AG's 3-Year EBITDA Growth Rate Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MediClin AG's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where MediClin AG's 3-Year EBITDA Growth Rate falls into.



MediClin AG 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.


MediClin AG  (XTER:MED) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


MediClin AG 3-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of MediClin AG's 3-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


MediClin AG (XTER:MED) Business Description

Traded in Other Exchanges
Address
Okenstrasse 27, Offenburg, DEU, 77652
MediClin AG is a company engaged in operating hospitals. It is focused on providing services in the areas of neurosciences and psychological sciences as well as orthopedics in Germany. The hospitals are acute-care hospitals providing basic, standard, and specialized care, as well as specialist clinics for medical rehabilitation. The operating segments of the group are Post-acute, Acute and Other activities. It generates majority of the revenue from the Post-acute segment in which the firm offers services in the fields of subsequent nursing treatment and curative treatment. Subsequent nursing treatment starts after acute care treatment and includes all medical measures required to facilitate the healing process and return the patient to a functioning state.

MediClin AG (XTER:MED) Headlines